European partnership fostering a European Research Area (ERA) for health research

Last updated: 21.7.2025
Grant

The European Partnership fostering a European Research Area (ERA) for health research aims to create a more resilient, inclusive, and democratic European society by significantly reducing the burden of diseases worldwide. This co-funded initiative under Horizon Europe focuses on advancing health research through collaborative efforts and innovative interventions, driving better understanding, prevention, diagnosis, and treatment of various diseases.

Who is Funded: Advancing European Health Research

This program broadly supports a wide array of entities and organizations committed to advancing health research across Europe and beyond. It targets those who can contribute to improving public health and healthcare systems through research, innovation, and policy development. The primary objective is to tackle diseases and reduce their burden globally, aligning with broader European health strategies.

What is Funded: Priority Health Sectors and Project Types

The program funds a diverse range of research and innovation activities across critical health sectors, with a particular emphasis on addressing major societal health challenges. It supports initiatives from foundational research to implementation, including clinical studies, aiming to develop and validate effective health interventions and technologies. Covered costs generally relate to eligible project activities, with specific rules for financial support to third parties.

Type and Scope of Funding: Financial Support Details

The European partnership operates as a co-funded program, providing financial support primarily through grants to projects that align with its health research objectives. The funding is structured in phases over seven years, with significant EU contributions aimed at leveraging national and regional investments. The program outlines clear financial limits and a specific funding rate for eligible costs.

Conditions and Requirements: Ensuring Program Integrity

Applicants and beneficiaries must adhere to specific conditions and requirements throughout the application process and project implementation. These include administrative stipulations, collaboration guidelines for consortia, and budgetary restrictions, all designed to ensure effective and responsible research and innovation within the health sector.

Application Procedure: Past Call Overview

The application process for this call has concluded, with proposals having undergone a single-stage submission and evaluation procedure. While the call is now closed, future applicants for similar Horizon Europe co-funded partnerships can refer to the general guidelines provided for proposal submission and evaluation.

The European Partnership fostering a European Research Area (ERA) for health research is established and governed by a comprehensive legal framework, primarily rooted in the Horizon Europe program. This framework ensures adherence to EU financial regulations and aligns the partnership's objectives with broader European policies on health and digital transformation.

Similar Programs

#European health research#ERA health#health funding Europe#disease burden reduction#clinical studies health#Horizon Europe Health#EU research funding#public health innovation#diagnostic technologies#therapeutic advancements#personalized medicine#antimicrobial resistance#non-communicable diseases#rare diseases#health systems resilience#co-funded partnerships#investigator-initiated clinical studies

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

10,000,000 EUR

Allocated Budget

Allocated Budget:

Total EU contribution expected: 110,000,000 EUR (30,000,000 EUR for Phase 1; 80,000,000 EUR for Phase 2)

Deadline

Deadline:

21.04.2022

Open Until

Open Until:

Ongoing

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

EU Member States, countries associated to Horizon Europe, and other countries wishing to join. Participation of third countries is encouraged. Legal entities established in the United States of America are eligible.

Sectors

Sectors:

Healthcare, Medical Technology, Pharmaceutical Industry, Research and Development, Environmental and Climate Protection, Information and Communication Technology, Software Development, Financial Technology, Green Technology, Other

Beneficiaries

Beneficiaries:

Health care providers, patients, citizens, public health systems

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Basic Research, Applied Research, Experimental Development, Prototyping, Pilot Testing, Product Development, Process Optimization, Market Introduction, Commercialization, Planning, Policy Development, Implementation, Service Delivery, Capacity Building, Awareness Campaigns, Monitoring, Evaluation, Other

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

Additional Partners:

European Clinical Research Infrastructure Network (ECRIN), Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), EU4Health Programme, Digital Europe Programme (DIGITAL), European Social Fund Plus (ESF+), European Regional Development Fund (ERDF), InvestEU, Recovery and Resilience Facility (RRF), Technical Support Instrument (TSI), World Health Organization (WHO)

0 x 0
XS